Notice

The Society of Hyperdisciplinarity, Osaka 2025] A New Book on "Behavior Change" / September 6, 2025 (Sat.) 15:10-16:00

2025.07.11

[Hyperdisciplinarity Conference Osaka 2025] Super-Deconstruction of "Behavior Change" / Saturday, September 6, 2025, 15:10-16:00.

The Hyper Interdisciplinary Conference Osaka 2025, organized by Liverness, will hold the session "A New Book on 'Behavior Change'" (session partner: Humanome Institute, Inc.).

The Association of Hyperdifferent Fields, Osaka 2025 Details

Improving health, continuing to learn, changing work styles - human behavior is always at the root of social issues. No matter how advanced the technology, society will not change unless behavior changes. In this session, practitioners at the forefront of AI and bio-data utilization will gather to thoroughly dissect what "change" means, the technologies that support change, and the design to break through the stagnant period when change is not possible. Furthermore, by adding the perspective of social implementation, we will take on the challenge of significantly developing the concept of behavior change on a scale appropriate for the 100-year life era.

We will have a program of discussions with researchers, ventures, and companies from a variety of perspectives, not limited to the themes of this session. For more information,Conference Websitefor more information.

A New Book on Behavior Change

Date: Saturday, September 6, 2025, 15:10-16:00
Place: Grand Cube Osaka (Osaka Prefectural International Convention Center)
(5-3-51 Nakanoshima, Kita-ku, Osaka City, Osaka Prefecture)

speaker

Mr. Shun Maekawa
General Manager, Research and Development Office, Humanome Research Institute, Inc.

D. from the Graduate School of Advanced Science and Engineering, Waseda University. Specialized in animal physiology, he joined Humanome Research Institute, Inc. in 2023. He has been engaged in data analysis and AI model development in the field of life science. Through his work in health measurement data analysis, disease prediction AI construction, and biomarker search, he promotes cross-disciplinary problem solving by integrating his expertise and data science. Also engaged in educational activities such as planning and teaching AI seminars for beginners.

Mr. Shun Nogawa
General Manager, Research and Development Department, GeneQuest Corporation

In 2017, he joined GeneQuest Inc. after completing his Master's degree in Bioscience and Biotechnology (Engineering) at Tokyo Institute of Technology (now Tokyo University of Science). At the university, he conducted research on bioinformatics analysis mainly on RNA sequence data, and after joining the company, he has consistently conducted statistical analysis mainly on genome data and research using data analysis on genomes. As Director of Research and Development, he is responsible for developing contents of genome analysis services for general consumers, as well as proposing and promoting collaborative research using collected genome data. He has conducted joint research with more than 30 companies and academia, and has published more than 40 academic conferences and 13 papers, including 2 papers as the first author.

Mr. Ryu Nakaki
Rhelixa, Inc. Representative Director, CEO / CTO

Computational Biologist (Ph.D. in Engineering). D. from the Graduate School of Engineering, The University of Tokyo. He specializes in the development and application of computational algorithms for the analysis of whole genome and epigenome data obtained from next-generation sequencers. In February 2015, he founded Rhelixa Inc. and was elected as a councilor of the Japanese Society of Anti-Aging Medicine at the 16th Annual Meeting of the Japanese Society of Anti-Aging Medicine in recognition of his achievements in the field of anti-aging medicine. He was elected as a councilor of the Japanese Society of Anti-Aging Medicine.

Moderator.

Joe Inoue
Leave a Nest Co., Ltd. President and Representative Director CCO

D., Pharmacist, founded Leave a Nest Co., Ltd. in 2002 while still in graduate school. After completing his PhD process, he worked as an Assistant Professor and Lecturer at the Faculty of Science, Kitasato University, Assistant Professor at the Graduate School of Medicine, Kyoto University, and Specially Appointed Associate Professor at Keio University before assuming and concurrently serving as Professor of Advanced Pharmaceutical Sciences at the Faculty of Pharmaceutical Sciences, Kumamoto University and Visiting Professor at the Faculty of Pharmaceutical Sciences, Keio University from 2018. He is a researcher and manager involved in launching joint research projects with universities and research institutions and supporting the establishment of research institutes while conducting research and development. He has also been involved in the establishment of many venture companies and serves as an advisor.

Registration for auditing is now open.

We look forward to welcoming many people from academia, local businesses, venture companies, large corporations, town factories, producers, local governments, junior high school, high school and technical college students, and others to the Hyperdifferent Fields Conference.

Click here to register to attend or participate.

Contact Us

For inquiries regarding this matter, please contact

Liverness Corporation (Takeshi Inoue and Seno)
TEL: 03-5227-4198
e-mail : [email protected]